172 related articles for article (PubMed ID: 30796820)
1. Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.
Chauhan SB; Faleiro R; Kumar R; Ng S; Singh B; Singh OP; Singh SS; Amante F; Rivera FL; Rai M; Chakravarty J; Sacks D; Nylen S; Sundar S; Engwerda C
J Infect Dis; 2019 Jun; 220(1):163-173. PubMed ID: 30796820
[TBL] [Abstract][Full Text] [Related]
2. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
[TBL] [Abstract][Full Text] [Related]
3. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8
Rodrigues LS; Barreto AS; Bomfim LGS; Gomes MC; Ferreira NLC; da Cruz GS; Magalhães LS; de Jesus AR; Palatnik-de-Sousa CB; Corrêa CB; de Almeida RP
Front Immunol; 2021; 12():773983. PubMed ID: 34777391
[TBL] [Abstract][Full Text] [Related]
5. Effector functions of Th17 cells are regulated by IL-35 and TGF-β in visceral leishmaniasis.
Asad M; Sabur A; Kamran M; Shadab M; Das S; Ali N
FASEB J; 2021 Sep; 35(9):e21755. PubMed ID: 34383962
[TBL] [Abstract][Full Text] [Related]
6. Distinct Roles for CD4
Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.
Tiwananthagorn S; Iwabuchi K; Ato M; Sakurai T; Kato H; Katakura K
PLoS Negl Trop Dis; 2012; 6(8):e1798. PubMed ID: 22928057
[TBL] [Abstract][Full Text] [Related]
8. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
[TBL] [Abstract][Full Text] [Related]
9. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
Wolday D; Berhe N; Britton S; Akuffo H
AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
[TBL] [Abstract][Full Text] [Related]
13. Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani.
Bhattacharya P; Ghosh S; Ejazi SA; Rahaman M; Pandey K; Ravi Das VN; Das P; Goswami RP; Saha B; Ali N
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004422. PubMed ID: 26829554
[TBL] [Abstract][Full Text] [Related]
14. A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.
Edwards CL; Engel JA; de Labastida Rivera F; Ng SS; Corvino D; Montes de Oca M; Frame TC; Chauhan SB; Singh SS; Kumar A; Wang Y; Na J; Mukhopadhyay P; Lee JS; Nylen S; Sundar S; Kumar R; Engwerda CR
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917177
[TBL] [Abstract][Full Text] [Related]
15. Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response.
Singh MK; Jamal F; Dubey AK; Shivam P; Kumari S; Pushpanjali ; Bordoloi C; Narayan S; Das VNR; Pandey K; Das P; Singh SK
Cytokine; 2019 Jan; 113():200-215. PubMed ID: 30001865
[TBL] [Abstract][Full Text] [Related]
16. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
17. Live Attenuated
Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.
Chowdhury BP; Das S; Majumder S; Halder K; Ghosh S; Biswas S; Bandyopadhyay S; Majumdar S
Pathog Dis; 2015 Nov; 73(8):ftv063. PubMed ID: 26297915
[TBL] [Abstract][Full Text] [Related]
19. Leishmania donovani infection of a susceptible host results in CD4+ T-cell apoptosis and decreased Th1 cytokine production.
Das G; Vohra H; Rao K; Saha B; Mishra GC
Scand J Immunol; 1999 Mar; 49(3):307-10. PubMed ID: 10102649
[TBL] [Abstract][Full Text] [Related]
20. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
